These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Hypertrophic intraventricular flow obstruction after very-low-dose dexamethasone (Minidex) in preterm infants: case presentation and review of the literature. Paech C; Wolf N; Thome UH; Knüpfer M J Perinatol; 2014 Mar; 34(3):244-6. PubMed ID: 24573211 [TBL] [Abstract][Full Text] [Related]
26. L-selectin expression on polymorphonuclear leukocytes and monocytes in premature infants: reduced expression after dexamethasone treatment for bronchopulmonary dysplasia. Waisman D; Van Eeden SF; Hogg JC; Solimano A; Massing B; Bondy GP J Pediatr; 1998 Jan; 132(1):53-6. PubMed ID: 9470000 [TBL] [Abstract][Full Text] [Related]
27. [Glucocorticoide therapy in premature infants: French practices in 2006]. Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441 [TBL] [Abstract][Full Text] [Related]
28. Dexamethasone increases plasma amino acid concentrations in bronchopulmonary dysplasia. Williams AF; Jones M Arch Dis Child; 1992 Jan; 67(1 Spec No):5-9. PubMed ID: 1536587 [TBL] [Abstract][Full Text] [Related]
29. Renal calcification after dexamethasone in infants with bronchopulmonary dysplasia. Kamitsuka MD; Peloquin D Lancet; 1991 Mar; 337(8741):626. PubMed ID: 1671989 [No Abstract] [Full Text] [Related]
33. Diabetic ketoacidosis after steroid administration for bronchopulmonary dysplasia: a case report. Spear ML; Reeves G; Pearlman SA J Perinatol; 1993; 13(3):232-4. PubMed ID: 8345389 [No Abstract] [Full Text] [Related]
34. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone. Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597 [TBL] [Abstract][Full Text] [Related]
35. Corticosteroids for the treatment and prevention of bronchopulmonary dysplasia. Soll RF Neonatology; 2010; 98(2):109-10. PubMed ID: 20150749 [No Abstract] [Full Text] [Related]
36. Delayed Dexamethasone Therapy and Neurodevelopmental Outcomes in Preterm Infants with Bronchopulmonary Dysplasia. Lim G; Lee BS; Choi YS; Park HW; Chung ML; Choi HJ; Kim EA; Kim KS Pediatr Neonatol; 2015 Aug; 56(4):261-7. PubMed ID: 25649722 [TBL] [Abstract][Full Text] [Related]
37. Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review. Doyle LW; Ehrenkranz RA; Halliday HL Neonatology; 2010; 98(4):289-96. PubMed ID: 20453523 [TBL] [Abstract][Full Text] [Related]
38. Hypertrophy of the tongue associated with inhaled corticosteroid therapy in premature infants. Linder N; Kuint J; German B; Lubin D; Loewenthal R J Pediatr; 1995 Oct; 127(4):651-3. PubMed ID: 7562295 [TBL] [Abstract][Full Text] [Related]
39. [Effect of corticosteroids on lung function and the clinical course of bronchopulmonary dysplasia in premature infants with a birth weight below 1,500 g]. Hanssler L; Zhou C; Roll C; Wiesemann HG Klin Padiatr; 1994; 206(5):372-6. PubMed ID: 7799612 [TBL] [Abstract][Full Text] [Related]
40. Changes in the plasma aminogram of parenterally fed infants treated with dexamethasone for bronchopulmonary dysplasia. Ng PC; Brownlee KG; Kelly EJ; Henderson MJ; Smith M; Dear PR Arch Dis Child; 1992 Oct; 67(10 Spec No):1193-5. PubMed ID: 1444557 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]